Document is current
Any future updates will be listed below
-
Authors
Englander, Honora http://orcid.org/0000-0003-1863-2041
Jones, Amy
Krawczyk, Noa
Patten, Alisa
Roberts, Timothy
Korthuis, P. Todd
McNeely, Jennifer
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (UG1DA015815, R01DA045669)
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 12 April 2022
First Online: 9 May 2022
Declarations
:
: Dr. Englander, Amy Jones, Dr. Krawczyk, Alisa Patten, Timothy Roberts, and Dr McNeely have no relevant conflicts of interest. Dr. Korthuis has no financial conflicts of interest, but serves as principal investigator for NIH-funded trials that accept donated study medications from Alkermes (extended-release naltrexone) and Indivior (sublingual buprenorphine).
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Free to read: This content has been made available to all.
